[Prevalence of metabolic syndrome in a population of obese children and adolescents]. 2012

M A Guadalupe Guijarro de Armas, and Susana Monereo Megías, and María Merino Viveros, and Paloma Iglesias Bolaños, and Belén Vega Piñero
Servicio Endocrinología y Nutrición, Hospital Universitario de Getafe, Madrid, España. docguada@hotmail.com

BACKGROUND Childhood obesity is a major and increasing health problem for society because it increases the risk of cardiovascular disease, type 2 diabetes mellitus, and hypertension. Thus, when obese children become obese adults, effects on their health and life expectation may be devastating. OBJECTIVE 1) To assess the prevalence of metabolic syndrome (MS) in a child population with obesity. and 2). To compare anthropometric and biochemical parameters in patients with one or two parameters of MS syndrome to those of patients who meet MS criteria. METHODS A descriptive, cross-sectional study was conducted in children and adolescents with severe obesity (weight>p97) seen at the endocrinology department of Hospital de Getafe. Variables examined included age, sex, height, weight, body mass index (BMI),waist circumference(WC), oral glucose tolerance test (OGTT), insulin, insulin resistance (IR) measured by HOMA, triglycerides (TG), HDL, and systolic and diastolic blood pressure (SBP and DBP). The definition of MS in adolescents was made according to criteria of the International Diabetes Federation (IDF), 2007. RESULTS A total of 133 patients, 67 males (50.4%) and 66 females (49.6%) with a mean age of 12.17 ± 3.27 years, were enrolled into the study. All patients were obese, with a weight greater than the 97 h percentile for age and sex. Prevalence of several cardiovascular risk factors was as follows: WC ≥ 90th percentile for age and sex, 100%; hypertension, 26.08%; hypertriglyceridemia ≥ 150 mg/dL, 15.94%; HDL <40 mg/dL, 10.86%; fasting blood glucose levels ≥ 100mg/dL, 7.97%. The overall prevalence of metabolic syndrome was 19.6%. A comparison of different anthropometric and biochemical parameters in patients with 1 or 2 MS criteria to those with 3 or more criteria showed that obesity and insulin resistance were significantly greater the greater the number of MS criteria met. CONCLUSIONS 1.) Prevalence of MS in obese children and adolescents is high, 2). Arterial hypertension and hypertriglyceridemia are the most prevalent metabolic changes in the population studied and 3). Early intervention to control childhood obesity is essential to prevent cardiovascular morbidity and mortality in the future.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010044 Outpatient Clinics, Hospital Organized services in a hospital which provide medical care on an outpatient basis. Ambulatory Care Facilities, Hospital,Hospital Outpatient Clinics,Clinic, Hospital Outpatient,Clinics, Hospital Outpatient,Hospital Outpatient Clinic,Outpatient Clinic, Hospital
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females

Related Publications

M A Guadalupe Guijarro de Armas, and Susana Monereo Megías, and María Merino Viveros, and Paloma Iglesias Bolaños, and Belén Vega Piñero
June 2006, Diabetes research and clinical practice,
M A Guadalupe Guijarro de Armas, and Susana Monereo Megías, and María Merino Viveros, and Paloma Iglesias Bolaños, and Belén Vega Piñero
October 2007, Anales de pediatria (Barcelona, Spain : 2003),
M A Guadalupe Guijarro de Armas, and Susana Monereo Megías, and María Merino Viveros, and Paloma Iglesias Bolaños, and Belén Vega Piñero
January 2012, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
M A Guadalupe Guijarro de Armas, and Susana Monereo Megías, and María Merino Viveros, and Paloma Iglesias Bolaños, and Belén Vega Piñero
July 2015, Journal of pediatric endocrinology & metabolism : JPEM,
M A Guadalupe Guijarro de Armas, and Susana Monereo Megías, and María Merino Viveros, and Paloma Iglesias Bolaños, and Belén Vega Piñero
August 2011, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
M A Guadalupe Guijarro de Armas, and Susana Monereo Megías, and María Merino Viveros, and Paloma Iglesias Bolaños, and Belén Vega Piñero
January 2012, La Tunisie medicale,
M A Guadalupe Guijarro de Armas, and Susana Monereo Megías, and María Merino Viveros, and Paloma Iglesias Bolaños, and Belén Vega Piñero
July 2018, Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki),
M A Guadalupe Guijarro de Armas, and Susana Monereo Megías, and María Merino Viveros, and Paloma Iglesias Bolaños, and Belén Vega Piñero
January 2016, Revista chilena de pediatria,
M A Guadalupe Guijarro de Armas, and Susana Monereo Megías, and María Merino Viveros, and Paloma Iglesias Bolaños, and Belén Vega Piñero
October 2008, International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity,
M A Guadalupe Guijarro de Armas, and Susana Monereo Megías, and María Merino Viveros, and Paloma Iglesias Bolaños, and Belén Vega Piñero
December 2006, Pediatric endocrinology reviews : PER,
Copied contents to your clipboard!